Diagnostic challenges in cyclic Cushing’s syndrome
Neoplastic versus nonneoplastic cortisol excess – eliminating confusion?
Long-term psychiatric comorbidity in Cushing’s syndrome – another call for early diagnosis?
Use of radiotherapy in the treatment of pituitary adenoma or craniopharyngioma – time to reassess the risk?
Thromboprophylaxis in patients with Cushing’s syndrome
Cushing’s syndrome induced by medullary thyroid cancer
Glucose-dependent insulinotropic polypeptide (GIP)-dependent primary bilateral macronodular adrenal hyperplasia with Cushing’s syndrome
Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing’s syndrome
Approach to the patient treated with steroidogenesis inhibitors
Management of Cushing’s syndrome in the time of COVID-19 (pub highlight)
Patients with active Cushing’s syndrome may be immunocompromised, and so require strict adherence to barrier methods to prevent infection with COVID-19. Clinical practice guidelines lay out the key principles of care of these patients during the pandemic, including algorithms for investigations and management of the syndrome.